Martingale Asset Management L P Fulgent Genetics, Inc. Transaction History

Martingale Asset Management L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$29.39 - $36.27 $75,150 - $92,742	2,557 Added 9.35%	29,909 $933,000
Q4 2022 Feb 13, 2023	BUY	$29.23 - $40.28 $177,016 - $243,935	6,056 Added 28.44%	27,352 $814,000
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $289,064 - $485,890	7,623 Added 55.75%	21,296 $812,000
Q2 2022 Aug 11, 2022	SELL	$47.98 - $62.75 $130,649 - $170,868	-2,723 Reduced 16.61%	13,673 $745,000
Q1 2022 May 12, 2022	BUY	$49.85 - $96.11 $817,340 - $1.58 Million	16,396 New	16,396 $1.02 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.